Clinical Trial

Improving Social Functioning in People With Substance Use and Mental Health Disorders Using VR

Study acronym: ROPVR
Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated January 23, 2026 (before its estimated June 2026 completion). Its status may not reflect the trial's current state.
Summary
ROPVR, a multi-centre, pragmatic randomized controlled trial (RCT) aims to evaluate a VR-technology which has been developed within an exploratory study and a development study, which facilitates social functioning among persons with a substance use and mental health disorder. Investigators will test a VR-program versus treatment as usual among patients enrolled into a long-term addiction-treatment facility. The RCT aims to evaluate the effectiveness of VR training compared to treatment as usual in improving resilience, quality of life, practical and social functioning and social participation (from baseline to 6 months), and to evaluate the cost-effectiveness of VR training versus treatment as usual.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2024-11-05.
Status change: Not Yet Recruiting → Recruiting 2026-01-21
Trial Details
NCT Number NCT06677515
Lead Sponsor Sykehuset Innlandet HF
Conditions Substance Use Disorders, Mental Disorder
Enrollment 102 participants
Start Date 2025-05-08
Primary Completion 2026-06 (estimated)
Study Completion 2026-12 (estimated)
Updated on ClinicalTrials.gov 2026-01-23